Mayor shares mental health struggles to help men
A mayor has backed plans for a men's mental health "taskforce" after speaking about his struggles following the death of his father.
Mayor of York and North Yorkshire David Skaith said he shut himself off after losing his father Bob in 2021, but said speaking about his feelings, sports and socialising helped him come to terms with his loss.
Mr Skaith was speaking at a council meeting discussing plans to improve men's mental health in the region.
He said: "Men will go running and go to the gym but how much are we actually doing to look after our head space too?"
The mayor, authority officials, NHS and charity representatives, and public health specialists discussed the plans, according to the Local Democracy Reporting Service.
Mr Skaith said: "After losing my dad during the coronavirus pandemic I completely shut myself off and I stopped spending time with my family and friends.
"I wasn't doing anything to care for myself, it wasn't until I went back to sport and being back in that environment with other people started to help."
The mayor said he hoped York and North Yorkshire could lead the way in shifting the dial on men's mental health.
The meeting heard suicide was the biggest killer of men aged 50 and under, and that an estimated four in five men would experience some form of mental health issue during their lives.
They discussed how mental health issues could be tackled locally, particularly given the amount of men working in traditionally male-dominated professions such as farming and the military.
Officials suggested using sport, fitness and pitching mental health self-care to encourage men to become more conscious of the issue.
Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Barbers train to talk to men about mental health
Improving transport at coast is key - new mayor
Local Democracy Reporting Service
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
13 minutes ago
- Medscape
Radiology Workforce Shortages Impacting Cancer Care
A chronic shortage of radiologists and oncologists is putting patients in the UK at risk, a new report found. The annual workforce census by the Royal College of Radiologists (RCR) warned that the safe delivery of NHS cancer care is becoming 'increasingly impossible' due to an escalating shortfall of doctors coupled with rising demand for care. In 2024, the UK had a 29% shortfall of clinical radiologists, with regional gaps ranging from 25% in Scotland to 32% in Wales. The workforce grew by 4.7% that year — less than in 2023, when it increased by 6.3%. The college forecasts the radiologist shortfall will reach 39% by 2029. Oncology Under Strain Clinical oncologists are also in short supply, with a current 15% gap expected to rise to 19% by 2029. This is despite a 5.4% increase in the workforce in 2024—the strongest growth since 2018. The RCR reported that 23% of cancer centres were experiencing recruitment freezes, making it harder to meet growing demand. Demand Continues to Outpace Capacity The shortages threaten the government's plans to cut waiting times and improve cancer outcomes. In 2024, demand for computerised tomography (CT) and magnetic resonance imaging (MRI) grew by 8%, but workforce growth did not keep pace. Every radiology leader surveyed last year reported delays to diagnostic scans caused by staff shortages. Nine in 10 radiology team leaders reported that patients were waiting longer to start treatment, while seven in 10 expressed concern that staff shortages were putting patient safety at risk – down slightly from 85% in 2023. Chronic problems such as workforce shortages, reporting backlogs, and staff vacancies remain too high, according to Dr Robin Proctor, the RCR's m edical director responsible for professional practice and clinical radiology. Consultants Leaving Earlier Staff retention is worsening, with experienced consultants leaving the NHS at younger ages. In 2024, the median age of consultant clinical radiologists leaving the NHS workforce was 50 – down from 56 in 2020. Four in five (79%) of leavers were under 60, and two in five (42%) were under 45. Clinical oncologists followed a similar trend. Their median exit age dropped to 54, from 57 in 2023 and 59 in 2022. Nearly 76% of leavers were under 60, and 26% were under 45. One consultant clinical oncologist told the college that delays in scans and treatment were resulting in missed or late cancer diagnoses. Some patients' conditions were deteriorating or reaching a stage where treatment was no longer possible. Changing Work Practices 'Working conditions and ways of working need to change if we are to address this problem and meet the growing demand for our expertise,' Proctor said. The RCR has called on the government to invest in training and recruitment. In 2024, the NHS spent an estimated £325 million on temporary radiology staff. The cost of outsourcing had doubled since before the COVID-19 pandemic and had surged by almost a quarter in the past year. The RCR estimated that increasing radiology trainee numbers by 50% could eliminate three-quarters of the current shortfall and save the NHS £460 million over the next 10 years. 'Patients are being failed by a chronic lack of radiologists and oncologists,' said RCR president Dr Katharine Halliday. 'The longer we delay action, the worse it gets,' she added.
Yahoo
25 minutes ago
- Yahoo
Alzheimer's blood test ‘can accurately pick up early symptoms'
A new blood test for Alzheimer's disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia, by examining two proteins in blood plasma. These proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque build-up, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has already been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Dr Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who show no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. He added: 'This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline – though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US – we hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Oakley said: 'Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before. 'We must see long-term investment in the tools and workforce needed to ensure everyone living with dementia can get an early an accurate diagnosis, which is even more important with disease-modifying treatments on the horizon.' Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40, and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting. 'In the UK, studies like the Blood Biomarker Challenge are helping to build this evidence. 'The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK. 'This work will be a crucial part of making diagnosis easier and faster, which will bring us closer to a cure.'
Yahoo
35 minutes ago
- Yahoo
New £24m surgery ward has 'cut waiting lists'
A new hospital unit has cut waiting lists for surgeries by carrying out 5,000 operations in its first year, it has claimed. The £24m Elective Surgery Hub at the Princess Royal Hospital in Telford carries out planned procedures like gall bladder removals and hysterectomies. It opened last June to improve the efficiency of elective surgeries and reduce waiting times. In the past year, Shrewsbury and Telford Hospitals NHS Trust reported a trust-wide fall of 16% in waiting times. The hub itself found surgical activity rose by 34% each month since January. Mr Saurav Chakravartty, a consultant surgeon at the hub who specialises in upper gastrointestinal and bariatric or weight loss surgery, said: "In the last twelve months, we've operated on close to 5,000 patients and you can see [our work] in the reduction of waiting lists," he said. The unit performs gynaecology, vascular, ophthalmology, orthopaedic, breast, upper GI, Ear, Nose and Throat (ENT) and maxillofacial procedures, in addition to general surgery. Ward manager Maj Kaur added that "up to 45" patients could be operated on daily and patients were usually discharged the same day. "Because we're in one space, there's not so many delays," she said. Matron Clare Marsh said the unit was based on a loop where patients moved from admission pods to one of four "state-of-the-art" theatres and finally recovery, where extra space for visitors and staff had received "amazing feedback". The straight-forward nature of the unit makes things simpler for patients, Ms Kaur added. "I think when you're having surgery you're quite stressed and anxious, so this really calms patients down. "Visitors can stay in the pods with their relatives which is nice because sometimes you're waiting a while before you go into theatre." Mr Chakravartty said when staff could do their jobs well and got positive feedback from patients, it boosted morale. "Staff want to do more and get their patients seen early - you can see the enthusiasm," he added. Follow BBC Shropshire on BBC Sounds, Facebook, X and Instagram. New surgery hub opens at hospital Delays caused staffing issues for new surgery unit GP surgeries to get £900,000 boost
